Client Alerts & Insights
Ohio Board of Pharmacy Answers Key Questions
October 18, 2021
Authored By:
Today, the State of Ohio Board of Pharmacy released the first set of Q&A responses for its second round of Medical Marijuana Dispensary Request for Applications. The Q&A responses can be found on the Medical Marijuana Control Program website. Over 200 questions were submitted ranging from questions on sources of capital, to site plan requirements. In the responses, the Board of Pharmacy has provided key guidance to applicants as they put together their applications for more Medical Marijuana Dispensary Licenses. This guidance will be instrumental to applicants as they navigate the application requirements and prepare the numerous required submissions to place their names in the hat for the license lottery.
One aspect of the application, the survey requirement, has generated a lot of questions from interested parties. In its responses, the Board of Pharmacy has made it clear that the survey “must be completed by a third-party, licensed professional.” They have further elaborated that there is no specific map required for the survey but that it must “contain all required information, be clearly legible and labeled, and may be divided into 8.4 by 11 inch sections.” Applicants will need to carefully review these Q&A responses to ensure that they are taking note of all guidance while preparing their application submissions.
The second Q&A period began on October 17, 2021 and will end on October 21, 2021. Questions may be submitted by emailing the medical marijuana control program. If Applicants have additional questions after reviewing the first Q&A responses, they will need to submit questions during the second Q&A period as this is the last opportunity they will have to receive guidance from the Board of Pharmacy.
If you need assistance with submitting questions to the Board of Pharmacy or with preparing your application for submission, the Benesch team is happy to assist. Reach out to one of our Regulated Industry experts to learn how we can help with your application.
Rob Zimmerman at rzimmerman@beneschlaw.com or 216.363.4437.
Kristopher J. Chandler at kchandler@beneschlaw.com or 614.223.9377.
Latest News
California AG’s Carbon Health Settlement Raises the Stakes for MSO-PC Structures and Continuity Planning in California
The California Attorney General’s June 2026 settlement with Carbon Health marks the first-of-its kind resolution of an enforcement action directly targeting an MSO-PC structure under California’s corporate practice of medicine (“CPOM”) doctrine.
Supply Chain Security – C-TPAT Program Growing in Significance for U.S. Operations
Geopolitical challenges are triggering executive-level focus on supply chain security across industrial sectors and transportation service providers, including renewed interest in the Customs-Trade Partnership against Terrorism (“C-TPAT”) program.
BREAKING: Seventh Circuit Holds Text Messages are not Telephone Calls Under Section 227(c)(5) of the TCPA
In a significant post-Loper Bright win for defendants, the Seventh Circuit issued its decision in Steidinger v. Blackstone Medical Services, No. 25-2398, affirming a trial court ruling that “§ 227(c)(5) [of the TCPA] does not permit plaintiffs to sue for the receipt of unwanted texts . . . .”
Connecticut’s New PFAS Rules: What Businesses Need to Know About the Regulations and Covered Product Categories
Connecticut has joined the growing roster of states cracking down on per- and polyfluoroalkyl substances (“PFAS”), the so-called “forever chemicals” long prized for their water resistance, stain resistance, and non-stick performance.